Open access · OA
via Europe PMC
Red Light Therapy and Mitochondrial Rejuvenation in Age-Related Disorders.
Iglewska M, Flis KA, Kołakowska M, Hryniewicz WW, Pluto-Prądzyńska A.
Molecular neurobiology · 2026
Mitochondrial dysfunction
Stem-cell exhaustion
Altered intercellular communication
Cell culture / in vitro
Human
In vitro
Review
Abstract
Aging is associated with mitochondrial dysfunction(definition), impaired ATP production, and a decline in tissue regenerative capacity, leading to the development of age-related diseases. This review summarizes current evidence regarding the effects of photobiomodulation (PBM) on mitochondrial function and age-related disorders. PBM using red and near-infrared light may enhance proper mitochondrial function by acting on cytochrome c oxidase (CCO) and other signaling pathways, including the transient receptor potential vanilloid 1 (TRPV1) channel, leading to increased ATP production, modulation of ROS signaling, and improved cellular homeostasis. We review in vitro, animal, and clinical studies investigating PBM in metabolic, neurodegenerative, hepatic, cardiovascular, age-related macular degeneration (AMD), and skeletal muscle disorders associated with aging, as well as its application in the management of cancer therapy-related oral mucositis. Current studies demonstrate beneficial effects on glucose metabolism, cardiovascular function, neuronal function, lipid metabolism, liver function, muscle regeneration, and visual function in AMD, as well as the safety and efficacy of PBM in the management of cancer therapy-induced oral mucositis. The therapeutic effects of PBM appear to be dose-dependent and influenced by treatment parameters including wavelength, fluence, irradiance, and exposure protocol. Although photobiomodulation still lacks standardized treatment protocols and differences exist in the wavelengths used, dosage, and frequency among studies, it represents a promising therapeutic approach for the treatment of age-related diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1007/s12035-026-06294-w
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
M, I., KA, F., M, K., WW, H., & A., P. (2026). Red Light Therapy and Mitochondrial Rejuvenation in Age-Related Disorders. <em>Molecular neurobiology</em>. https://doi.org/10.1007/s12035-026-06294-w
Vancouver
M I, KA F, M K, WW H, A. P. Red Light Therapy and Mitochondrial Rejuvenation in Age-Related Disorders. Molecular neurobiology. 2026. doi:10.1007/s12035-026-06294-w.
BibTeX
@article{iglewska2026RedLig,
title = {Red Light Therapy and Mitochondrial Rejuvenation in Age-Related Disorders.},
author = {Iglewska M and Flis KA and Kołakowska M and Hryniewicz WW and Pluto-Prądzyńska A.},
journal = {Molecular neurobiology},
year = {2026},
doi = {10.1007/s12035-026-06294-w},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
GeroScience 2026
Citation only
Therapeutic potential of MitoQ, a mitochondria-targeted antioxidant, in age-related physiological dysfunction.
The Journal of Physiology 2012
Preprint · OA
Potentiating exercise training with resveratrol
PROTEOMICS 2020
Preprint · OA
Mitochondrial Dysfunction in Age‐Related Metabolic Disorders
Diabetes & Metabolism Journal 2013
Open access · CC-BY
SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential
Oxidative Medicine and Cellular Longevity 2013
Open access · CC-BY
Renal Protective Effects of Resveratrol
HAL 2018
Preprint · OA